DXCM News and Press, DexCom Inc. From 05/17/23

2023-05-17 08:45:00 ET Many companies are bracing for a recession this year, and one looks to be coming, with gross domestic product up just 1.1% in the first quarter of 2023, below expectations. But that doesn't mean all businesses are going to be struggling. DraftKings (NASDAQ: ...

2023-05-14 21:26:02 ET Summary Medtronic has faced hurdles of its own making over the last three years. The company's pipeline, however, has recently delivered some wins. We believe that MDT stock is likely to re-rate as the new products continue to come online. ...

JDS conference seminars and information at the Dexcom booth will demonstrate Dexcom CGM is central to optimal diabetes management for people with both Type 1 and Type 2 diabetes, including older adults DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose moni...

2023-05-04 21:05:51 ET Summary Baillie Gifford’s 13F portfolio value increased from ~$96B to ~$111B this quarter. They increased Advanced Micro Devices, Duolingo, and Meta Platforms while reducing Elevance Health, Alphabet, AJ Gallagher & Co, and Booking Holdings. T...

2023-05-04 16:20:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2023, Baron Health Care Fund declined 3.69%, compared w...

2023-05-03 07:45:42 ET DexCom ( NASDAQ: DXCM ) prices offering of $1.1B aggregate principal amount of 0.375% convertible senior notes due 2028 in a private placement. The aggregate principal amount of the offering was increased from the previously announced offering size o...

DexCom, Inc. (Nasdaq: DXCM) (“Dexcom”) announced today the pricing of its offering of $1.1 billion aggregate principal amount of 0.375% Convertible Senior Notes due 2028 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional b...

For people with diabetes treated with insulin, Dexcom rtCGM is associated with significant improvements over patients’ lifetimes and is likely to be cost-saving to the NHS DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for peopl...

2023-05-02 17:00:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During the first quarter, Baron Opportunity Fund® climbed 17.96% (Institutional S...

2023-05-02 07:25:43 ET DexCom ( NASDAQ: DXCM ) intends to offer $1B aggregate principal amount of convertible senior notes due 2028 in a private placement. Initial purchasers will be granted an option to purchase, within a 13-day period from up to an additional $150M princ...